Works matching IS 01676997 AND DT 2016 AND VI 34 AND IP 5
Results: 15
In vitro and in vivo antineoplastic and immunological effects of pterocarpanquinone LQB-118.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 541, doi. 10.1007/s10637-016-0359-2
- By:
- Publication type:
- Article
Pharmacokinetics and excretion of C-omacetaxine in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 565, doi. 10.1007/s10637-016-0360-9
- By:
- Publication type:
- Article
Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in unrecognised early pregnancy.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 650, doi. 10.1007/s10637-016-0361-8
- By:
- Publication type:
- Article
Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 654, doi. 10.1007/s10637-016-0363-6
- By:
- Publication type:
- Article
Involvement of AMP-activated protein kinase in mediating pyrrolo-1,5-benzoxazepine-induced apoptosis in neuroblastoma cells.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 663, doi. 10.1007/s10637-016-0366-3
- By:
- Publication type:
- Article
Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 575, doi. 10.1007/s10637-016-0367-2
- By:
- Publication type:
- Article
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 625, doi. 10.1007/s10637-016-0368-1
- By:
- Publication type:
- Article
Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 636, doi. 10.1007/s10637-016-0369-0
- By:
- Publication type:
- Article
A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 584, doi. 10.1007/s10637-016-0370-7
- By:
- Publication type:
- Article
Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 596, doi. 10.1007/s10637-016-0371-6
- By:
- Publication type:
- Article
Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor - belinostat - in glioblastoma cell lines: a preliminary report.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 552, doi. 10.1007/s10637-016-0372-5
- By:
- Publication type:
- Article
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 604, doi. 10.1007/s10637-016-0374-3
- By:
- Publication type:
- Article
A phase I trial of the aurora kinase inhibitor , ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 614, doi. 10.1007/s10637-016-0375-2
- By:
- Publication type:
- Article
The renal effects of ALK inhibitors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 643, doi. 10.1007/s10637-016-0379-y
- By:
- Publication type:
- Article
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 531, doi. 10.1007/s10637-016-0358-3
- By:
- Publication type:
- Article